BR9608662A - Composto processo para a preparação de compostos e composição farmacêutica - Google Patents

Composto processo para a preparação de compostos e composição farmacêutica

Info

Publication number
BR9608662A
BR9608662A BR9608662A BR9608662A BR9608662A BR 9608662 A BR9608662 A BR 9608662A BR 9608662 A BR9608662 A BR 9608662A BR 9608662 A BR9608662 A BR 9608662A BR 9608662 A BR9608662 A BR 9608662A
Authority
BR
Brazil
Prior art keywords
alkyl
compounds
preparation
pharmaceutical composition
alkoxy
Prior art date
Application number
BR9608662A
Other languages
English (en)
Inventor
Domenico Badone
Marco Baroni
Rosanna Cardamone
Jacqueline Fournier
Umberto Guzzi
Alessandra Ielmini
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of BR9608662A publication Critical patent/BR9608662A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BR9608662A 1995-06-28 1996-06-26 Composto processo para a preparação de compostos e composição farmacêutica BR9608662A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9507760A FR2736053B1 (fr) 1995-06-28 1995-06-28 Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines
PCT/FR1996/000995 WO1997001536A1 (fr) 1995-06-28 1996-06-26 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines ayant une activite neurotrophique et neuroprotectrice

Publications (1)

Publication Number Publication Date
BR9608662A true BR9608662A (pt) 1999-05-04

Family

ID=9480466

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608662A BR9608662A (pt) 1995-06-28 1996-06-26 Composto processo para a preparação de compostos e composição farmacêutica

Country Status (30)

Country Link
US (1) US5981754A (pt)
EP (2) EP1216996A3 (pt)
JP (2) JP3147906B2 (pt)
KR (1) KR100460581B1 (pt)
CN (1) CN1153765C (pt)
AT (1) ATE223897T1 (pt)
AU (1) AU715090B2 (pt)
BR (1) BR9608662A (pt)
CA (1) CA2225746C (pt)
CY (1) CY2312B1 (pt)
CZ (1) CZ291075B6 (pt)
DE (1) DE69623631T2 (pt)
DK (1) DK0837848T3 (pt)
EE (1) EE03870B1 (pt)
ES (1) ES2183965T3 (pt)
FR (1) FR2736053B1 (pt)
HK (1) HK1014952A1 (pt)
HU (1) HUP9900055A3 (pt)
IL (1) IL122159A (pt)
IS (1) IS1999B (pt)
NO (1) NO310144B1 (pt)
NZ (1) NZ312723A (pt)
PL (2) PL192353B1 (pt)
PT (1) PT837848E (pt)
RU (1) RU2163237C2 (pt)
SK (2) SK283707B6 (pt)
TR (1) TR199701710T1 (pt)
UA (1) UA62914C2 (pt)
WO (1) WO1997001536A1 (pt)
ZA (1) ZA965527B (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2762514B1 (fr) 1997-04-29 1999-10-22 Sanofi Sa Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation
FR2763847B1 (fr) 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
FR2771007B1 (fr) * 1997-11-14 2000-12-01 Sanofi Sa Association de principes actifs pour le traitement de la demence senile du type alzheimer
FR2771006B1 (fr) * 1997-11-14 2000-12-01 Sanofi Sa Association de principes actifs pour le traitement de la demence senile du type alzheimer
CO4980891A1 (es) * 1997-11-14 2000-11-27 Sanofi Sa Asociacion de principios activos para el tratamiento de la demencia senil de tipo azheimer
EP1087962A4 (en) * 1998-06-19 2001-10-04 Lilly Co Eli PRODUCTION OF HETEROARYL COMPOUNDS
FR2803593B1 (fr) * 2000-01-06 2002-02-15 Sanofi Synthelabo Nouvelles tetrahydropyridines, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2823748B1 (fr) * 2001-04-20 2004-02-20 Sanofi Synthelabo Tetrahydropyridyl-alkyl-benzodiazines, procede pour leur preparation et compositions pharmaceutiques les contenant
WO2002085888A1 (fr) * 2001-04-20 2002-10-31 Sanofi-Synthelabo Tetrahydropyridyl-alkyl-heterocycles, procede pour leur preparation et compositions pharmaceutiques les contenants
FR2840896B1 (fr) * 2002-06-18 2005-04-08 Sanofi Synthelabo Phenyl-et pyridyl-piperazines, procede pour leur preparation et compositions pharmaceutiques les contenant
KR100956052B1 (ko) * 2002-12-16 2010-05-06 미쓰비시 타나베 파마 코퍼레이션 3-치환-4-피리미돈 유도체
JP4866610B2 (ja) 2003-08-18 2012-02-01 富士フイルムファインケミカルズ株式会社 ピリジルテトラヒドロピリジン類およびピリジルピペリジン類
TWI350168B (en) * 2004-05-07 2011-10-11 Incyte Corp Amido compounds and their use as pharmaceuticals
AU2005267331A1 (en) * 2004-06-24 2006-02-02 Incyte Corporation Amido compounds and their use as pharmaceuticals
MXPA06014574A (es) * 2004-06-24 2007-03-12 Incyte Corp Piperidinas n-sustituidas y su uso como farmaceuticos.
EP1768954A4 (en) * 2004-06-24 2008-05-28 Incyte Corp 2-METHYLPROPANAMIDES AND THEIR USE AS PHARMACEUTICALS
JP2008504279A (ja) * 2004-06-24 2008-02-14 インサイト・コーポレイション アミド化合物およびその医薬としての使用
WO2006002349A1 (en) * 2004-06-24 2006-01-05 Incyte Corporation Amido compounds and their use as pharmaceuticals
EA200700251A1 (ru) * 2004-08-10 2007-08-31 Инсайт Корпорейшн Амидосоединения и их применение в качестве фармацевтических средств
US8110581B2 (en) * 2004-11-10 2012-02-07 Incyte Corporation Lactam compounds and their use as pharmaceuticals
TWI400239B (zh) * 2004-11-10 2013-07-01 Incyte Corp 內醯胺化合物及其作為醫藥品之用途
MX2007005820A (es) * 2004-11-18 2007-07-18 Incyte Corp Inhibidores de deshidrogenasa esteroide hidroxilo 11-beta tipo 1 y metodos de uso de los mismos.
FR2883285B1 (fr) * 2005-03-17 2007-05-18 Sanofi Aventis Sa Sel besylate de la 7-(2-(4-(3-trifluoromethyl-phenyl) -1,2,3,6-tetrahudro-pyrid-1-yl)ethyl) isoquinoleine, sa preparation et son utilisation en therapeutique
JP4864342B2 (ja) * 2005-04-27 2012-02-01 北興化学工業株式会社 ビアリール化合物の製造方法
CA2621255A1 (en) * 2005-09-21 2007-04-05 Incyte Corporation Amido compounds and their use as pharmaceuticals
AU2006322060A1 (en) * 2005-12-05 2007-06-14 Incyte Corporation Lactam compounds and methods of using the same
WO2007084314A2 (en) * 2006-01-12 2007-07-26 Incyte Corporation MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
WO2007089683A1 (en) * 2006-01-31 2007-08-09 Incyte Corporation Amido compounds and their use as pharmaceuticals
TW200808807A (en) * 2006-03-02 2008-02-16 Incyte Corp Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
US20070208001A1 (en) * 2006-03-03 2007-09-06 Jincong Zhuo Modulators of 11- beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
WO2007130898A1 (en) * 2006-05-01 2007-11-15 Incyte Corporation TETRASUBSTITUTED UREAS AS MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1
WO2007137066A2 (en) * 2006-05-17 2007-11-29 Incyte Corporation HETEROCYCLIC INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME
CL2008001839A1 (es) 2007-06-21 2009-01-16 Incyte Holdings Corp Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
AU2008345573B2 (en) 2007-12-20 2013-12-19 Envivo Pharmaceuticals, Inc. Tetrasubstituted benzenes
IN2012DN06383A (pt) * 2010-01-19 2015-10-02 Bayer Ip Gmbh
US10858351B2 (en) 2017-04-26 2020-12-08 Alberta Research Chemicals Inc. Substituted tetrahydropyridine derivatives as IDO-1 inhibitors and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0398578B1 (en) * 1989-05-17 1997-03-12 Pfizer Inc. 2-piperidino-1-alkanol derivatives as antiischemic agents
FR2650505B1 (fr) * 1989-08-07 1994-06-03 Midy Spa Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
DE4325855A1 (de) * 1993-08-02 1995-02-09 Boehringer Ingelheim Kg Neue Benzoesäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
NO310144B1 (no) 2001-05-28
US5981754A (en) 1999-11-09
PL324216A1 (en) 1998-05-11
EP0837848B1 (fr) 2002-09-11
WO1997001536A1 (fr) 1997-01-16
DE69623631D1 (en) 2002-10-17
HUP9900055A3 (en) 1999-11-29
PL192353B1 (pl) 2006-10-31
CY2312B1 (en) 2003-11-14
NO976079D0 (no) 1997-12-23
KR19990028431A (ko) 1999-04-15
CN1153765C (zh) 2004-06-16
SK285433B6 (sk) 2007-01-04
PL187087B1 (pl) 2004-05-31
RU2163237C2 (ru) 2001-02-20
ES2183965T3 (es) 2003-04-01
FR2736053B1 (fr) 1997-09-19
IS4641A (is) 1997-12-23
EP1216996A3 (fr) 2003-10-15
JP2001114763A (ja) 2001-04-24
CN1189154A (zh) 1998-07-29
KR100460581B1 (ko) 2005-04-14
AU715090B2 (en) 2000-01-13
CZ291075B6 (cs) 2002-12-11
SK178197A3 (en) 1998-07-08
AU6461996A (en) 1997-01-30
EE03870B1 (et) 2002-10-15
NZ312723A (en) 1999-10-28
IS1999B (is) 2005-04-15
IL122159A0 (en) 1998-04-05
MX9710472A (es) 1998-03-31
CA2225746A1 (en) 1997-01-16
PT837848E (pt) 2002-12-31
TR199701710T1 (xx) 1998-05-21
EE9700348A (et) 1998-06-15
EP0837848A1 (fr) 1998-04-29
IL122159A (en) 2001-06-14
HK1014952A1 (en) 1999-10-08
JP3302351B2 (ja) 2002-07-15
CA2225746C (en) 2004-05-18
FR2736053A1 (fr) 1997-01-03
DE69623631T2 (de) 2003-08-07
HUP9900055A2 (hu) 1999-04-28
SK283707B6 (sk) 2003-12-02
CZ422297A3 (cs) 1998-04-15
ATE223897T1 (de) 2002-09-15
JP3147906B2 (ja) 2001-03-19
JPH11506118A (ja) 1999-06-02
UA62914C2 (en) 2004-01-15
ZA965527B (en) 1997-01-24
EP1216996A2 (fr) 2002-06-26
NO976079L (no) 1997-12-23
DK0837848T3 (da) 2003-01-06

Similar Documents

Publication Publication Date Title
BR9608662A (pt) Composto processo para a preparação de compostos e composição farmacêutica
AU3437695A (en) New piperidine compounds, process for their preparation and the pharmaceutical compositions which contain them
AU560579B2 (en) N-aromatic-n:-cycloalkylalkanoyl-piperazines
ATE285403T1 (de) Verfahren zur herstellung von n-((4- phenyl)methylphenyl)piperazinen
UA41928C2 (uk) Похідні оксазолідину, спосіб їх одержання, фармацевтична композиція та спосіб її одержання, спосіб лікування захворювань
AU4440397A (en) New heterocyclic aminomethyl compounds, process for preparing them and pharmaceutical compositions containing them
AU1498895A (en) Novel aminoalkyl benzoazolinones and benzothiazolinones, process for their preparation and the pharmaceutical compositions which contain them
IL116386A0 (en) Use of 1,2 bridged 1,4 dihydropyridines and process for their prepration
PT98444A (pt) Processo para a preparacao de um novo antibiotico, balimicina, e de composicoes farmaceuticas que o contem
ATE199897T1 (de) Aminierte 6,7,8,9-tetrahydro- cyclopenta(a)naphthalen- und 2,3-dihydro- cyclopenta(e)inden-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE69612416D1 (de) Thiophenverbindungen, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
PT100104A (pt) Processo para a preparacao de aminoalcanos substituidos

Legal Events

Date Code Title Description
TE Change of address
HHT Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: republication

Free format text: ALTERADO A SEDE CONFORME PEDIDO NA PETICAO 047197/RJ DE 24/11/2000 REF. RPI 1570 DE 06/02/2001. COD. 25.7, ITEM (71)

PC Transfer

Free format text: SANOFI SYNTHELABO (FR)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/06/1996, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS (FR)

Free format text: ALTERADO DE: SANOFI-SYNTHELABO

B24C Patent annual fee: request for for restoration

Free format text: REFERENTE A 13A E 14A ANUIDADE(S).

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A DESPACHO 24.3, PUBLICADO NA RPI 2110 DE 14/06/2011.